Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy

被引:0
|
作者
Ryota Nakanishi
Eiji Oki
Hirofumi Hasuda
Eiki Sano
Yu Miyashita
Akihiro Sakai
Naomichi Koga
Naotaka Kuriyama
Kentaro Nonaka
Yoshiaki Fujimoto
Tomoko Jogo
Kentaro Hokonohara
Qingjiang Hu
Yuichi Hisamatsu
Koji Ando
Yasue Kimura
Tomoharu Yoshizumi
Masaki Mori
机构
[1] Kyushu University,Department of Surgery and Science, Graduate School of Medical Sciences
来源
Annals of Surgical Oncology | 2021年 / 28卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2975 / 2985
页数:10
相关论文
共 50 条
  • [1] Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy
    Nakanishi, Ryota
    Oki, Eiji
    Hasuda, Hirofumi
    Sano, Eiki
    Miyashita, Yu
    Sakai, Akihiro
    Koga, Naomichi
    Kuriyama, Naotaka
    Nonaka, Kentaro
    Fujimoto, Yoshiaki
    Jogo, Tomoko
    Hokonohara, Kentaro
    Hu, Qingjiang
    Hisamatsu, Yuichi
    Ando, Koji
    Kimura, Yasue
    Yoshizumi, Tomoharu
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 2975 - 2985
  • [2] Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases
    Giannini, Valentina
    Pusceddu, Laura
    Defeudis, Arianna
    Nicoletti, Giulia
    Cappello, Giovanni
    Mazzetti, Simone
    Sartore-Bianchi, Andrea
    Siena, Salvatore
    Vanzulli, Angelo
    Rizzetto, Francesco
    Fenocchio, Elisabetta
    Lazzari, Luca
    Bardelli, Alberto
    Marsoni, Silvia
    Regge, Daniele
    CANCERS, 2022, 14 (01)
  • [3] CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy
    Qi, Wei
    Yang, Jing
    Zheng, Longbo
    Lu, Yun
    Liu, Ruiqing
    Ju, Yiheng
    Niu, Tianye
    Wang, Dongsheng
    MEDICAL PHYSICS, 2023, 50 (05) : 2705 - 2714
  • [4] ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis
    Nakanishi, Ryota
    Oki, Eiji
    Hasuda, Hirofumi
    Sano, Eiki
    Miyashita, Yu
    Sakai, Akihiro
    Koga, Naomichi
    Kuriyama, Naotaka
    Nonaka, Kentaro
    Fujimoto, Yoshiaki
    Jogo, Tomoko
    Hokonohara, Kentaro
    Hu, Qingjiang
    Hisamatsu, Yuichi
    Ando, Koji
    Kimura, Yasue
    Yoshizumi, Tomoharu
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 2986 - 2987
  • [5] ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis
    Ryota Nakanishi
    Eiji Oki
    Hirofumi Hasuda
    Eiki Sano
    Yu Miyashita
    Akihiro Sakai
    Naomichi Koga
    Naotaka Kuriyama
    Kentaro Nonaka
    Yoshiaki Fujimoto
    Tomoko Jogo
    Kentaro Hokonohara
    Qingjiang Hu
    Yuichi Hisamatsu
    Koji Ando
    Yasue Kimura
    Tomoharu Yoshizumi
    Masaki Mori
    Annals of Surgical Oncology, 2021, 28 : 2986 - 2987
  • [6] Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases
    Daniel Brock Hewitt
    Timothy M. Pawlik
    Jordan M. Cloyd
    Annals of Surgical Oncology, 2021, 28 : 2931 - 2933
  • [7] Who Will Benefit? Using Radiomics to Predict Response to Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastases
    Hewitt, Daniel Brock
    Pawlik, Timothy M.
    Cloyd, Jordan M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 2931 - 2933
  • [8] Identification of an immunological prognostic factor for metastatic colorectal cancer patients treated with first-line oxaliplatin-based chemotherapy
    Tada, K.
    Shoji, H.
    Kitano, S.
    Nishimura, T.
    Shimada, Y.
    Nagashima, K.
    Ito, A.
    Honma, Y.
    Iwasa, S.
    Okita, N.
    Takashima, A.
    Kato, K.
    Yamada, Y.
    Katayama, N.
    Boku, N.
    Heike, Y.
    Hamaguchi, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S80 - S80
  • [9] Capecitabine combined with oxaliplatin (XELOX) as first-line chemotherapy in colorectal cancer with liver metastases
    Mahfouf, H.
    Djeddi, H.
    Belhadef, S.
    Bouzid, K.
    Bentabak, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy
    Ono, Tomojiro
    Ishida, Hideyuki
    Kumamoto, Kensuke
    Okada, Norimichi
    Ishibashi, Keiichiro
    ONCOLOGY LETTERS, 2012, 4 (05) : 905 - 909